
Evolent Health, Inc.
EVHNYSECIK 1628908IndustrialsFiscal year ends Dec 31
Reports and events: 235 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0320:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000169 |
| 2023-11-0217:18 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628908-23-000165 |
| 2023-11-0216:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-23-000162 |
| 2023-10-1617:35 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001628908-23-000149 |
| 2023-09-2617:28 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000141 |
| 2023-08-0416:51 ET | 8-K/A | 8.01 Other events | 0001628908-23-000130 |
| 2023-08-0318:14 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628908-23-000121 |
| 2023-08-0216:16 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000119 |
| 2023-07-2616:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-23-000115 |
| 2023-06-0816:15 ET | 8-K | 5.07 Shareholder vote results | 0001628908-23-000076 |
| 2023-05-2308:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-23-000069 |
| 2023-05-0419:40 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628908-23-000066 |
| 2023-05-0316:15 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628908-23-000061 |
| 2023-04-2816:06 ET | DEF 14A | Proxy statement | 0001193125-23-126887 |
| 2023-04-1916:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-23-000056 |
| 2023-03-2916:01 ET | 8-K | 1.02 Termination of a material agreement | 0001628908-23-000051 |
| 2023-02-2417:09 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628908-23-000029 |
| 2023-02-2216:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-23-000014 |
| 2023-02-1516:23 ET | 8-K | 8.01 Other events | 0001628908-23-000010 |
| 2023-01-2308:01 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-012645 |
| 2023-01-1106:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-23-000005 |
| 2022-11-1716:04 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-22-000154 |
| 2022-11-1020:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-22-000151 |
| 2022-11-0316:28 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001628908-22-000141 |
| 2022-11-0216:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-22-000138 |
| 2022-10-1107:32 ET | 8-K | 7.01 Regulation FD disclosure | 0001628908-22-000134 |
| 2022-09-0616:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628908-22-000129 |
| 2022-08-2516:46 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-22-002543 |
| 2022-08-1816:05 ET | 8-K | 3.02 Unregistered sale of equity | 0001628908-22-000116 |
| 2022-08-1217:40 ET | 8-K | 3.02 Unregistered sale of equity | 0001628908-22-000111 |
| 2022-08-0317:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-211393 |
| 2022-08-0316:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001628908-22-000098 |
| 2022-08-0216:17 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628908-22-000093 |
| 2022-07-1117:02 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-22-002211 |
| 2022-06-2906:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-22-000088 |
| 2022-06-0916:28 ET | 8-K | 5.07 Shareholder vote results | 0001628908-22-000067 |
| 2022-05-0916:11 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-22-001511 |
| 2022-05-0518:10 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001628908-22-000063 |
| 2022-05-0416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-22-000061 |
| 2022-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2022-06-09 | 0001193125-22-133588 |
| 2022-03-0708:01 ET | 8-K | 8.01 Other events | 0001628908-22-000050 |
| 2022-02-2417:57 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001628908-22-000027 |
| 2022-02-2316:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-22-000025 |
| 2022-02-1117:06 ET | 8-K | 8.01 Other events | 0001628908-22-000012 |
| 2022-01-1107:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-22-000003 |
| 2021-11-0517:11 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-21-002536 |
| 2021-11-0418:24 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001628908-21-000149 |
| 2021-11-0316:13 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-21-000142 |
| 2021-10-0416:14 ET | 8-K | 3.02 Unregistered sale of equity | 0001628908-21-000132 |
| 2021-08-0519:12 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001628908-21-000116 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 04:22 ET. Listed shows no prices and gives no investment advice.